Background A third of older people take five or more regular medications (polypharmacy).
Conducting medication reviews in primary care is key to identify and reduce/stop …

Some meta‐analyses suggest that deprescribing may reduce mortality. Our aim was to
determine the underlying factors contributing to this observed reduction. We analysed data …

Aims The aim of this study was to compare the clinical decision‐making for benzodiazepine
deprescribing between a healthcare provider (HCP) and an artificial intelligence (AI) chatbot …

Deprescribing is the intentional dose reduction or discontinuation of a medication. The
development of deprescribing interventions should take into consideration important …

Background Policies, protocols and processes within organisations can facilitate or hinder
guideline adoption. There is limited knowledge on the strategies used by organisations to …

Polypharmacy is common in older adults and is associated with adverse drug events,
cognitive and functional impairment, increased healthcare costs, and increased risk of frailty …

Aims Previous systematic reviews suggest that deprescribing may improve survival,
particularly in frail older people. Evidence is rapidly accumulating, suggesting a need for an …

Introduction For people with type 2 diabetes and/or cardiovascular conditions, deprescribing
of glucose-lowering, blood pressure-lowering and/or lipid-lowering medication is …

Background: Antibiotics have significantly reduced mortality and improved outcomes across
various medical fields; however, the rise of antibiotic resistance poses a major challenge …

The study Reeve J, Maden M, Hill R, et al. Deprescribing medicines in older people living
with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol …